Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism

Pharmacology Biochemistry and Behavior(2023)10.1016/j.pbb.2023.173530Source: DataRank Database

The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism is a research paper published in Pharmacology Biochemistry and Behavior (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.43)OA: greenTopics (38)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Warwick Mackie,Hunter D.J. Webb ORCID,Lucy R. Thomsen ORCID,Mhairi Nimick ORCID,Rhonda J. Rosengren ORCID

Live enrichment

PubMed:36805861 PMC:PMC10020421 OpenAlex:https://openalex.org/W4321189507

National Institute on Drug Abuse

Grant: DA-040460

NIDA NIH HHS

Grant: R01 DA040460

National Institutes of Health

Health Research Council of New Zealand

FWCI

0.43

Citation Percentile

0.6%

Citation Trend

2024

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10020421/pdf/nihms-1878142.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0091305723000175?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0091305723000175?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10020421

Fields of Study

Cannabis and Cannabinoid ResearchForensic Toxicology and Drug AnalysisNeurotransmitter Receptor Influence on BehaviorRatsMiceHumansAnimalsCannabinoid Receptor AgonistsPiperazineCannabinoidsIndazolesReceptor, Cannabinoid, CB1Valine

MeSH Terms

PiperazineAnimalsCannabinoidsHumansIndazolesValineReceptor, Cannabinoid, CB1MiceRatsCannabinoid Receptor Agonists

Keywords

Cannabinoid receptorCannabinoidAgonistPharmacologyCannabinoid Receptor AgonistsCannabinoid receptor type 2ReceptorMedicineInternal medicineTelemetryPlethysmographyCardiovascular EffectsPolypharmacologySynthetic Cannabinoid Receptor AgonistsParty Pills

Sustainable Development Goals

SDG 0: Reduced inequalities